Literature DB >> 18160479

Class II-restricted protective immunity induced by malaria sporozoites.

Giane A Oliveira1, Kota Arun Kumar, J Mauricio Calvo-Calle, Caroline Othoro, David Altszuler, Victor Nussenzweig, Elizabeth H Nardin.   

Abstract

The irradiated-sporozoite vaccine elicits sterile immunity against Plasmodium parasites in experimental rodent hosts and human volunteers. Based on rodent malaria models, it has been proposed that CD8+ T cells are the key protective effector mechanism required in sporozoite-induced immunity. To investigate the role of class II-restricted immunity in protective immunity, we immunized beta2-microglobulin knockout (beta2M-/-) mice with irradiated Plasmodium yoelii or P. berghei sporozoites. Sterile immunity was obtained in the CD8+-T-cell-deficient mice immunized with either P. berghei or P. yoelii sporozoites. beta2M-/- mice with the BALB/c (H-2d) genetic background as well as those with the C57BL (H-2b) genetic background were protected. Effector mechanisms included CD4+ T cells, mediated in part through the production of gamma interferon, and neutralizing antibodies that targeted the extracellular sporozoites. We conclude that in the absence of class I-restricted CD8+ T cells, sporozoite-induced protective immunity can be effectively mediated by class II-restricted immune effector mechanisms. These results support efforts to develop subunit vaccines that effectively elicit high levels of antibody and CD4+ T cells to target Plasmodium pre-erythrocytic stages.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160479      PMCID: PMC2258813          DOI: 10.1128/IAI.00566-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

1.  Plasmodium berghei: accelerated clearance of sporozoites from blood as part of immune-mechanism in mice.

Authors:  R S Nussenzweig; J P Vanderberg; Y Sanabria; H Most
Journal:  Exp Parasitol       Date:  1972-02       Impact factor: 2.011

2.  The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria.

Authors:  M Rodrigues; R S Nussenzweig; F Zavala
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

3.  Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity.

Authors:  R Nussenzweig; J Vanderberg; H Most
Journal:  Mil Med       Date:  1969-09       Impact factor: 1.437

4.  Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei.

Authors:  R S Nussenzweig; J Vanderberg; H Most; C Orton
Journal:  Nature       Date:  1967-10-14       Impact factor: 49.962

5.  CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein.

Authors:  A Moreno; P Clavijo; R Edelman; J Davis; M Sztein; F Sinigaglia; E Nardin
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

6.  Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.

Authors:  D F Clyde
Journal:  Am J Trop Med Hyg       Date:  1975-05       Impact factor: 2.345

7.  Quantitative Plasmodium sporozoite neutralization assay (TSNA).

Authors:  Kota Arun Kumar; Giane A Oliveira; Robert Edelman; Elizabeth Nardin; Victor Nussenzweig
Journal:  J Immunol Methods       Date:  2004-09       Impact factor: 2.303

8.  Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.

Authors:  S L Epstein; J A Misplon; C M Lawson; E K Subbarao; M Connors; B R Murphy
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

9.  LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice.

Authors:  D Muller; B H Koller; J L Whitton; K E LaPan; K K Brigman; J A Frelinger
Journal:  Science       Date:  1992-03-20       Impact factor: 47.728

10.  Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice.

Authors:  E Y Denkers; R T Gazzinelli; D Martin; A Sher
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  28 in total

Review 1.  Plasmodium immunomics.

Authors:  Denise L Doolan
Journal:  Int J Parasitol       Date:  2010-09-16       Impact factor: 3.981

2.  Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I·C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mice.

Authors:  Kathrin Kastenmüller; Diego A Espinosa; Lauren Trager; Cristina Stoyanov; Andres M Salazar; Santosh Pokalwar; Sanjay Singh; Sheetij Dutta; Christian F Ockenhouse; Fidel Zavala; Robert A Seder
Journal:  Infect Immun       Date:  2012-12-28       Impact factor: 3.441

3.  Trimethoprim-Sulfamethoxazole Prophylaxis During Live Malaria Sporozoite Immunization Induces Long-Lived, Homologous, and Heterologous Protective Immunity Against Sporozoite Challenge.

Authors:  Charlotte V Hobbs; Charles Anderson; Jillian Neal; Tejram Sahu; Solomon Conteh; Tatiana Voza; Jean Langhorne; William Borkowsky; Patrick E Duffy
Journal:  J Infect Dis       Date:  2016-10-17       Impact factor: 5.226

4.  Cutting edge: attrition of Plasmodium-specific memory CD8 T cells results in decreased protection that is rescued by booster immunization.

Authors:  Nathan W Schmidt; John T Harty
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

5.  CD4+ T cell response correlates with naturally acquired antibodies against Plasmodium vivax tryptophan-rich antigens.

Authors:  Mohammad Zeeshan; Kriti Tyagi; Yagya D Sharma
Journal:  Infect Immun       Date:  2015-03-02       Impact factor: 3.441

6.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

7.  Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites.

Authors:  Nathan W Schmidt; Noah S Butler; Vladimir P Badovinac; John T Harty
Journal:  PLoS Pathog       Date:  2010-07-15       Impact factor: 6.823

Review 8.  A retrospective evaluation of the role of T cells in the development of malaria vaccine.

Authors:  Moriya Tsuji
Journal:  Exp Parasitol       Date:  2009-11-26       Impact factor: 2.011

9.  Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites.

Authors:  Noah S Butler; Nathan W Schmidt; John T Harty
Journal:  J Immunol       Date:  2010-01-22       Impact factor: 5.422

Review 10.  HLA-DR: molecular insights and vaccine design.

Authors:  Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.